Alan Morgan
Chief Executive Officer
Alan is the Chief Executive Officer at Symbio, joining the company in November 2023. With 35 years of experience in the pharmaceutical and clinical research industries, Alan brings a wealth of expertise to his leadership role. His background includes global leadership roles at prominent CROs (Contract Research Organizations) such as ICON and Covance, as well as pharma experience with GSK and AstraZeneca. Additionally, he has served as a Non-Executive Board Director at Gentronix and Algorics.
Alan holds an FCCA BSc from City University London and is a Fellow of the Chartered Association of Certified Accountants (ACCA) in the UK.
Alan serves as Board Director for Symbio, Nuve.AI, and Porsolt SAS. He is also an Operating Partner at ARCHIMED, the healthcare specialist private equity firm.
Alan is passionate about delivering to customer needs; bringing together the best people, system and process with a collaborative, ‘can-do’ culture and optimal organization design.
Alan is based in the United Kingdom but is often to be found in a train, plane or automobile…